---
title: "Supernus Names Tony Kingsley Board Chair Following Indivior Merger"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303971111.md"
description: "Supernus Pharmaceuticals has appointed Tony Kingsley, a former Indivior director, as its new Board Chair following the completion of its merger with Indivior on November 2, 2026. The combined company's eight-member board consists of four directors from each legacy entity."
datetime: "2026-11-02T14:29:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303971111.md)
  - [en](https://longbridge.com/en/news/303971111.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303971111.md)
generator: "portal-rs"
---

# Supernus Names Tony Kingsley Board Chair Following Indivior Merger

-   Supernus named former Indivior director Tony Kingsley board chair following completion of the companies’ merger on November 2, 2026. \* The combined company’s eight-member board includes four directors from each legacy company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Supernus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-121014), on November 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [INDV.US](https://longbridge.com/en/quote/INDV.US.md)
- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)

## Related News & Research

- [Supernus Pharmaceuticals Seeks Nasdaq Delisting Following Merger Completion](https://longbridge.com/en/news/303985729.md)
- [Supernus Terminates UBS Credit Line Ahead of Indivior Merger](https://longbridge.com/en/news/303130886.md)
- [This Supernus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday](https://longbridge.com/en/news/304886043.md)
- [Supernus Pharmaceuticals Holds Special Stockholder Meeting](https://longbridge.com/en/news/302018511.md)
- [Supernus Awards 100,000 Restricted Stock Units to Senior VP Padmanabh Bhatt](https://longbridge.com/en/news/304008743.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**